BACKGROUND: A single nucleotide polymorphism (SNP) in the coding region of the prion protein gene (PRNP) at codon 129 has been repeatedly shown to be an associated factor to sporadic Creutzfeldt-Jakob disease (sCJD), but additional major predisposing DNA variants for sCJD are still unknown. Several previous studies focused on the characterisation of polymorphisms in PRNP and the prion-like doppel gene (PRND), generating contradictory results on relatively small sample sets. Thus, extensive studies are required for validation of the polymorphisms in PRNP and PRND. METHODS: We evaluated a set of nine SNPs of PRNP and one SNP of PRND in 593 German sCJD patients and 748 German healthy controls. Genotyping was performed using MALDI-TOF mass spectrometry. RESULTS: In addition to PRNP 129, we detected a significant association between sCJD and allele frequencies of six further PRNP SNPs. No significant association of PRND T174M with sCJD was shown. We observed strong linkage disequilibrium within eight adjacent PRNP SNPs, including PRNP 129. However, the association of sCJD with PRNP 1368 and PRNP 34296 appeared to be independent on the genotype of PRNP 129. We additionally identified the most common haplotypes of PRNP to be over-represented or under-represented in our cohort of patients with sCJD. CONCLUSION: Our study evaluated previous findings of the association of SNPs in the PRNP and PRND genes in the largest cohorts for association study in sCJD to date, and extends previous findings by defining for the first time the haplotypes associated with sCJD in a large population of the German CJD surveillance study.
BACKGROUND: A single nucleotide polymorphism (SNP) in the coding region of the prion protein gene (PRNP) at codon 129 has been repeatedly shown to be an associated factor to sporadic Creutzfeldt-Jakob disease (sCJD), but additional major predisposing DNA variants for sCJD are still unknown. Several previous studies focused on the characterisation of polymorphisms in PRNP and the prion-like doppel gene (PRND), generating contradictory results on relatively small sample sets. Thus, extensive studies are required for validation of the polymorphisms in PRNP and PRND. METHODS: We evaluated a set of nine SNPs of PRNP and one SNP of PRND in 593 German sCJD patients and 748 German healthy controls. Genotyping was performed using MALDI-TOF mass spectrometry. RESULTS: In addition to PRNP 129, we detected a significant association between sCJD and allele frequencies of six further PRNP SNPs. No significant association of PRNDT174M with sCJD was shown. We observed strong linkage disequilibrium within eight adjacent PRNP SNPs, including PRNP 129. However, the association of sCJD with PRNP 1368 and PRNP 34296 appeared to be independent on the genotype of PRNP 129. We additionally identified the most common haplotypes of PRNP to be over-represented or under-represented in our cohort of patients with sCJD. CONCLUSION: Our study evaluated previous findings of the association of SNPs in the PRNP and PRND genes in the largest cohorts for association study in sCJD to date, and extends previous findings by defining for the first time the haplotypes associated with sCJD in a large population of the German CJD surveillance study.
Authors: S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher Journal: Proc Natl Acad Sci U S A Date: 2001-05-15 Impact factor: 11.205
Authors: I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser Journal: Neurology Date: 2000-09-26 Impact factor: 9.910
Authors: K Manolakou; J Beaton; I McConnell; C Farquar; J Manson; N D Hastie; M Bruce; I J Jackson Journal: Proc Natl Acad Sci U S A Date: 2001-06-12 Impact factor: 11.205
Authors: O Windl; A Giese; W Schulz-Schaeffer; I Zerr; K Skworc; S Arendt; C Oberdieck; M Bodemer; S Poser; H A Kretzschmar Journal: Hum Genet Date: 1999-09 Impact factor: 4.132
Authors: B Schröder; B Franz; P Hempfling; M Selbert; T Jürgens; H A Kretzschmar; M Bodemer; S Poser; I Zerr Journal: Hum Genet Date: 2001-09 Impact factor: 4.132
Authors: Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero Journal: J Neurol Date: 2012-07-05 Impact factor: 4.849
Authors: Paula Singmann; Jens Baumert; Christian Herder; Christa Meisinger; Christina Holzapfel; Norman Klopp; H-Erich Wichmann; Martin Klingenspor; Wolfgang Rathmann; Thomas Illig; Harald Grallert Journal: Obes Facts Date: 2009-07-20 Impact factor: 3.942
Authors: Sol Moe Lee; Young Ran Ju; Bo-Yeong Choi; Jae Wook Hyeon; Jun Sun Park; Chi Kyeong Kim; Su Yeon Kim Journal: Prion Date: 2012-05-07 Impact factor: 3.931
Authors: Susanne Tan; André Scherag; Onno Eilard Janssen; Susanne Hahn; Harald Lahner; Tiina Dietz; Susann Scherag; Harald Grallert; Carla Ivane Ganz Vogel; Rainer Kimmig; Thomas Illig; Klaus Mann; Johannes Hebebrand; Anke Hinney Journal: BMC Med Genet Date: 2010-01-21 Impact factor: 2.103
Authors: Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge Journal: Lancet Neurol Date: 2009-01 Impact factor: 44.182